Drug industry opposed to incentive program for cheaper drugs.

The KPMA made it clear on Nov. 2, that the Association definitely opposed the government's incentive program for cheaper generic drugs to be more consumed at the medical institutes and the drug price reduction plans through the open public tenders as one of the government NHI financial stabilization measures.

The incentive program provides a certain rate of drug margins to the medical insti...